[Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
D000818:Animals; D000903:Antibiotics, Antineoplastic; D001681:Biological Assay; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000096:biosynthesis; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects; D012313:RNA / Q000096:biosynthesis
D000903:Antibiotics, Antineoplastic; D012313:RNA; D004247:DNA; D003630:Daunorubicin
Rubidomycin-daunomycin, et nyt antibiotikum med antineoplastisk effekt.